Navigation Links
ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
Date:8/8/2008

Conference call scheduled for August 12, 2008 at 1:30 p.m. (Pacific);

simultaneous webcast at http://www.adventrx.com

SAN DIEGO, Aug. 8 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) today announced that it will host a conference call with simultaneous webcast to discuss second quarter 2008 results on Tuesday, August 12th, 2008 at 1:30 p.m. Pacific / 4:30 p.m. Eastern. Evan M. Levine, Chief Executive Officer and President, and Mark N. K. Bagnall, Chief Financial Officer and Executive Vice President, will host the conference call.

The conference call may be accessed by dialing (888) 215-7027 for domestic callers and (913) 312-0654 for international callers. The webcast will be available live via the Internet by accessing ADVENTRX's website at http://www.adventrx.com under "Investors". Replays of the webcast will be available on ADVENTRX's website for 30 days and a phone replay will be available through September 12, 2008 by dialing (888) 203-1112 and entering the pass code 8240633.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease. The Company seeks to improve the performance and commercial potential of existing treatments by addressing problems associated with these treatment regimens. More information can be found on ADVENTRX's web site at http://www.adventrx.com.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ADVENTRX Settles Dispute With Former Licensee
2. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
3. ADVENTRX Appoints Vice President of Manufacturing
4. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
5. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
6. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
7. Eric K. Rowinsky Joins ADVENTRX Board of Directors
8. ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
9. ADVENTRX Announces Consolidation of Clinical and Management Positions
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
11. ADVENTRX Appoints Vice President of Commercialization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015   Cypher Genomics, Inc., ... Inc. (NASDAQ: SQNM ), the leading ... for next generation noninvasive prenatal tests (NIPT). Through ... technology, called Mantis™, to advance analysis of clinically-relevant ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval ... for the use of Medtronic,s SynchroMed ® II ... for use with United Therapeutics, Remodulin ® (treprostinil) ...
(Date:12/24/2014)... December 23, 2014 GMO corn cases filed ... are in the process of being consolidated in a Kansas ... Re: Syngenta AG MIR 162 Corn Litigation, MDL No. 2591 ... , Management of the Syngenta GMO corn multidistrict litigation (MDL) ...
(Date:12/24/2014)... 2014 The report provides basic ... classification, application and industry overview. This report also ... structure. Production is separated by regions, technology and ... equipment, downstream client survey, marketing channels, industry development ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... --- For more than 15 years, carbon nanotubes ... Researchers have conceived applications for nanotubes ranging from ... should, in theory, give them mechanical and electrical ... , Unfortunately, theory and experiments have failed to ...
... CHAPEL HILL, N.C., Aug. 15 The ... divided into multiple market,segments. In this challenging ... increasingly complex organizational and,decision-making structures to effectively ... only being influenced by medical professionals,focused on ...
... HARBIN, China, Aug. 15 /Xinhua-PRNewswire-FirstCall/ -- China Kangtai,Cactus ... a,vertically integrated grower, developer, manufacturer and marketer of ... today record,second quarter results for the period ended ... million, a 34.9% increase compared to $3.7 million,in ...
Cached Biology Technology:True properties of carbon nanotubes measured 2True properties of carbon nanotubes measured 3U.S. Hospital Sales Opportunities Maximized Through Functional Optimization 2China Kangtai Cactus Biotech Announces Record Second Quarter Results 2China Kangtai Cactus Biotech Announces Record Second Quarter Results 3
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a ... discovery, announced the launch of a TR-FRET (time ... company,s Transcreener UDP Assay, a high throughput screening ... new assay will allow for sensitive detection of ...
(Date:1/22/2015)... , Jan. 21, 2015  Analyst Report Issued by Small Cap ... report showed that planet-wide, transactions at merchants on the leading ... total number of credit, debit, and prepaid cards reached 6.54 ... victims of fraudulent card usage in 2012, and credit and ...
(Date:1/22/2015)... 22, 2015 Infinisource has launched its new NXG series ... The G2 sets a higher standard for collecting attendance and ... solution. With plug-and-play installation, touch screen interface and seamless connection ... robust time collection solution for the small to mid-size employer. ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Infinisource's NXG series sets new time clock standard 2
... that enables natural resource managers to take action ... climate changes. The Adaptation for Conservation Targets ... how future changes in air and water temperatures, ... might affect natural resources. ACT enables scientists and ...
... researchers led by Shawn P. McElmurry, Ph.D., P.E., assistant ... University,s College of Engineering, has confirmed that seasonal fluctuations ... areas throughout the United States and elsewhere in the ... with lead. The study, published in the ...
... , Feb. 27, 2013 /PRNewswire-iReach/ -- IntelliMedix announced that ... Board. Lammert is the Chairman and co-founder of the Epilepsy ... for FACES (Finding a Cure for Epilepsy and Seizures) at ... record accelerating innovation for new therapies in the field of ...
Cached Biology News:A game plan for climate change 2A game plan for climate change 3Warren Lammert Joins IntelliMedix Board of Advisors 2
... DW4 liquid handling system from Molecular Devices ... in one instrument. The system handles a ... plate washing96-, 384- and 1536-welland is the ... DW4 has been optimized to dispense from ...
... Radiochemical Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research ... availability of new radiolabeled ligands selected to ... a wide range of products and services ... over 400 state-of-the-art radioligands. If you do ...
... Radiolabeled Ligands\n\nReceptor-related research has long been enabled ... ligands selected to keep pace with new ... products and services for receptor research and ... If you do not find exactly what ...
... UltraPure Agarose and SYBR Safe DNA Gel Stain ... Saves money versus buying these same products separately ... alternative to ethidium bromide ... Agarose resolves DNA and RNA fragments from 100 bp ...
Biology Products: